Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment

Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment

Background Patients with multiple sclerosis (MS) demonstrate higher seroprevalence of Epstein-Barr virus (EBV) and increased anti-EBV IgG levels in serum compared with healthy controls. Intrathecal antibody production to measles virus (MeV) is a common finding in patients with MS.Objective To measur...

Full description

Bibliographic Details
Main Authors: Clemens Warnke, Tomas Olsson, Ingrid Kockum, Tomas Bergström, Anna Fogdell-Hahn, Linn Persson Berg, Marcus Eriksson, Sonia Longhi, Elisabeth Thomsson, Malin Bäckström
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:BMJ Neurology Open
Online Access:https://neurologyopen.bmj.com/content/4/2/e000271.full

Internet

https://neurologyopen.bmj.com/content/4/2/e000271.full

Similar Items